NCT03398876View on ClinicalTrials.gov

A Study to Assess the Nicotine Pharmacokinetics, Tolerability and Safety With a New Oral Nicotine Replacement Product in Healthy Japanese Smokers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 22, 2017

Primary Completion Date

April 16, 2018

Study Completion Date

April 16, 2018

Conditions
Healthy
Interventions
DRUG

Oromucosal Nicotine Spray (ONS)

Participants will receive oral dose of oromucosal nicotine spray (ONS).

DRUG

Nicotine Gum

Participants will chew nicotine gum for 30 minutes.

OTHER

Cigarette

Participants will smoke one cigarette as 10 puffs for 3 minutes.

Trial Locations (1)

8120025

Souseikai Hakata Clinic, Fukuoka

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutical K.K.

INDUSTRY